To achieve this, we combined our imaging pipeline with the in vivo administration of non-depleting fluorescent-tagged antibody (CD68-AF647) to label macrophages in the bi-clonal tumour model (Figure 1B). This evidence concerns the gene CD68 and neoplasm.